中型制药市场战略、顶级参与者、增长机会、2031 年分析和预测

  • Report Code : TIPRE00018321
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

中型医药市场规模预计将从 2023 年的 7,320.2 亿美元增至 2031 年的 12,240.39 亿美元。预计 2023-2031 年期间该市场的复合年增长率为 8.9%。更加注重研发可能仍将是市场的一个主要趋势。

中型医药市场分析

市场增长的关键驱动因素包括全球老年人口的增加以及慢性病患病率的上升。此外,城市化进程的加快也增加了政府在医疗保健领域的支出。此外,医疗保健初创企业数量的增加可能会在未来几年为中型制药市场带来机遇。

中型制药市场概况

人口老龄化和社会行为的变化导致这些常见且代价高昂的长期健康问题稳步增加。随着城市化进程的加快,人们的生活方式变得更加久坐不动。这增加了肥胖率和糖尿病等疾病的发病率。根据世界卫生组织的数据,到 2026 年,慢性病的患病率预计将增加 57%。新兴市场将受到最严重的打击,因为预计发展中国家的人口增长最为强劲。慢性病对医疗保健系统的需求不断增加已成为一个重大问题。

糖尿病是 21 世纪全球最大的健康问题之一。每年,越来越多的人患上这种疾病,导致改变生活的并发症。根据国际糖尿病联合会 (IDF) 的数据,2019 年北美糖尿病患者人数约为 4600 万人,预计到 2045 年将增加到 6200 万人。在预测期内,疾病患病率增加约 35%。大流行测试了感染在全球传播的速度。大流行对健康系统施加了周期性的巨大破坏性压力。全球各地的医疗机构都希望做好准备,一旦疫情集体爆发,就能够控制疫情。因此,慢性病患病率的上升推动了中型医药市场的发展。

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

中型制药市场:

Mid-Size Pharmaceutical Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

中型制药市场的驱动因素和机遇

提高产品批准和发布数量

中型制药市场的特点是存在各种市场参与者。为了增加市场份额,市场参与者采取了各种策略,例如产品发布、区域扩张和技术进步。中型制药公司更多地参与持续创新和技术进步,从而提高了行业参与者的接受度。领先的参与者投资研发以开发先进技术并获得更多收入。例如,2022 年 5 月,卫材株式会社推出了 MOVICOL HD,这是现有 MOVICOL LD 的先进配方,用于治疗慢性便秘。EA Pharma 和卫材株式会社根据共同推广协议合作提供有关正确使用 MOVICOL HD 的信息。此外,2022 年 5 月,Sun Pharmaceutical Industries Ltd.(包括其子公司和关联公司)宣布,其仿制美沙拉嗪缓释胶囊 500 毫克的简化新药申请 (ANDA) 已获得美国 FDA 的最终批准。仿制药批准是以 Pentasa 缓释胶囊 500 毫克作为参考产品。

医疗健康初创企业数量不断增加

在过去十年中,制药行业见证了许多变革趋势和创新,这些趋势和创新将迅速改善全球患者可用的药物。在短短十年内,人工智能和大数据对疾病诊断和治疗的影响以及向预防危及生命的疾病而不是用药的转变导致了医疗保健的演变。随着最近技术的发展,新进入者创办了几家健康初创公司,从而影响了中型制药市场。例如:Alpha Zyme 由开发和生产专家 Christopher Benoit 于 2018 年创立。2020 年 10 月,Alp zyme 与 Qualio 合作,促进公司的发展。

中型医药市场报告细分分析

有助于得出中型医药市场分析的关键部分是类型、药物开发类型、配方和治疗类别。

  • 根据类型,中型医药市场分为处方药和非处方药。非处方药在 2023 年占据了最大的市场份额。
  • 根据药物开发类型,中型制药市场分为内部开发和外包。外包部分在 2023 年占据了最大的市场份额。
  • 根据配方,中型制药市场分为片剂和胶囊、注射剂、喷雾剂和其他配方。片剂和胶囊细分市场在 2023 年占据最大市场份额。
  • 根据治疗类别,中型医药市场分为心血管疾病、疼痛管理、糖尿病、癌症和其他疾病。糖尿病领域在 2023 年占据了最大的市场份额。

中型制药市场份额(按地区)分析

中型医药市场报告的地理范围主要分为五个地区:北美、亚太、欧洲、中东和非洲、南美和中美。

美国是北美最大的中型制药市场。在北美,美国占据了中型制药市场的很大份额。该国市场的增长主要受到美国人口老龄化和慢性病患病率上升的推动。美国人口老龄化加剧可能会有利于中型制药市场的增长。根据美国人口普查局的数据,在美国,65 岁及以上的人预计将从 2018 年的 5200 万增加一倍至 2060 年的 9500 万左右,65 岁及以上人口的比例将从 2018 年的 16% 增加到 2060 年的 23%。

大多数成年人(>60%)患有两种或两种以上的慢性病。根据美国疾病控制与预防中心 (CDC) 的数据,2020 年,美国近 60% 的人患有至少一种慢性病,40% 的人患有两种或两种以上的慢性病。此外,痴呆症、心脏病、2 型糖尿病、关节炎和癌症等慢性病都与衰老有关。这些都是美国疾病、残疾、死亡和医疗成本上涨的重要原因。

 

中型制药市场区域洞察

Insight Partners 的分析师已详尽解释了预测期内影响中型制药市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的中型制药市场细分和地理位置。

Mid-Size Pharmaceutical Market
  • 获取中型医药市场的区域特定数据

中型医药市场报告范围

报告属性细节
2023 年的市场规模7,320.2亿美元
2031 年市场规模12,240.39亿美元
全球复合年增长率(2023 - 2031)8.9%
史料2021-2022
预测期2024-2031
涵盖的领域按类型
  • 处方
  • 在柜台
按药物研发类型
  • 内部和外包
按配方
  • 片剂和胶囊
  • 注射剂
  • 喷雾剂
  • 其他配方
按治疗类别
  • 心血管疾病
  • 疼痛管理
  • 糖尿病
  • 癌症
  • 其他条件
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 第一三共株式会社;
  • 卫材株式会社;
  • 再生元制药公司(Regeneron Pharmaceuticals, Inc)
  • 博士伦保健公司(Bausch Health Companies Inc.);
  • 太阳制药工业有限公司;
  • Alexion Pharmaceuticals, Inc.;
  • 马林克罗德;
  • Endo Pharmaceuticals Inc.;
  • 施维雅实验室;
  • 优时比公司

 

中型制药市场参与者密度:了解其对业务动态的影响

中型医药市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在中型制药市场运营的主要公司有:

  1. 第一三共株式会社;
  2. 卫材株式会社;
  3. 再生元制药公司(Regeneron Pharmaceuticals, Inc)
  4. 博士伦保健公司(Bausch Health Companies Inc.);
  5. 太阳制药工业有限公司;
  6. Alexion Pharmaceuticals, Inc.;

免责声明上面列出的公司没有按照任何特定顺序排列。


Mid-Size Pharmaceutical Market

 

  • 了解中型制药市场的主要参与者概况

中型制药市场新闻和最新发展

中型制药市场通过收集一手和二手研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下列出了中型制药市场的一些发展情况:

  • Regeneron Pharmaceuticals, Inc. 和 Checkmate Pharmaceuticals, Inc. 宣布达成最终协议,Regeneron 将以每股 10.50 美元的价格全现金收购 Checkmate 普通股。在拟议的收购中,Checkmate 的全部股票价值估计约为 2.5 亿美元。(来源:Regeneron Pharmaceuticals, Inc,公司网站,2022 年 4 月)

中型制药市场报告覆盖范围和交付成果

“中型制药市场规模和预测(2021-2031 年)”报告对市场进行了详细分析,涵盖以下领域:

  • 中型医药市场规模,以及范围内所有关键细分市场的全球、区域和国家层面的预测
  • 中型制药市场趋势以及市场动态,如驱动因素、限制因素和关键机遇
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 中型医药市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新的市场发展。
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及中型制药市场的最新发展
  • 详细的公司简介
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region dominated the mid-size pharmaceutical market in 2023?

North America dominated the mid-size pharmaceutical market in 2023

What are the driving factors impacting the mid-size pharmaceutical market?

The growth of the market is defined by key driving factors, such as the rising geriatric population across the globe, along with the increased prevalence of chronic disorders. Moreover, increased urbanization has increased government expenditures on the healthcare sector.

What are the future trends of the mid-size pharmaceutical market?

Greater focus on R&D will likely remain a key trend in the market.

Which are the leading players operating in the mid-size pharmaceutical market?

DAIICHI SANKYO COMPANY LIMITED; Eisai Co., Ltd.; Regeneron Pharmaceuticals, Inc; Bausch Health Companies Inc.; Sun Pharmaceutical Industries Ltd; Alexion Pharmaceuticals, Inc.; Mallinckrodt; Endo Pharmaceuticals Inc.; Les Laboratories Servier; and UCB S.A.

What is the expected CAGR of the mid-size pharmaceutical market?

The market is expected to register a CAGR of 8.9% during 2023–2031.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.